Organigram CEO Greg Engel steps down, Peter Amirault appointed on interim basis
Read this article for free:
Already have an account? Log in here »
To continue reading, please subscribe with this special offer:
All-Access Digital Subscription
$4.75 per week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Pay $19.00 every four weeks. GST will be added to each payment. Subscription can be cancelled anytime.
Hey there, time traveller!
This article was published 03/05/2021 (637 days ago), so information in it may no longer be current.
MONCTON, N.B. – Organigram Holdings Inc. says Greg Engel is stepping down from his chief executive post.
The Moncton, N.B.-based cannabis company did not offer details on Engel’s departure, but says he will continue to act as a special adviser to the board during a “transition period.
Organigram’s board chairman Peter Amirault has been appointed to serve as executive chair on an interim basis and oversee day-to-day management of the company until a new CEO is named.
Engel has led the company since 2017 and was recently involved with signing Organigram’s $221-million deal with British American Tobacco.
In the months leading up to the deal, Organigram announced it would cultivate less cannabis than its Moncton facilities were designed to produce.
It also laid off at least 220 workers, or roughly one-quarter of its staff.
This report by The Canadian Press was first published May 3, 2021.
Companies in this story: (TSX:OGI)